Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tetraphase Pharmaceu (TTPH)

Tetraphase Pharmaceu (TTPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,833
  • Shares Outstanding, K 3,466
  • Annual Sales, $ 18,900 K
  • Annual Income, $ -72,160 K
  • 60-Month Beta 2.40
  • Price/Sales 0.61
  • Price/Cash Flow N/A
  • Price/Book 0.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -5.68
  • Number of Estimates 1
  • High Estimate -5.68
  • Low Estimate -5.68
  • Prior Year -8.00
  • Growth Rate Est. (year over year) +29.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +9.18%
on 02/18/20
3.86 -41.45%
on 01/22/20
-0.70 (-23.65%)
since 01/21/20
3-Month
1.99 +13.57%
on 12/18/19
4.30 -47.44%
on 12/27/19
-0.13 (-5.44%)
since 11/21/19
52-Week
1.99 +13.57%
on 12/18/19
29.00 -92.21%
on 03/18/19
-22.34 (-90.81%)
since 02/21/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TTPH with:

Business Summary

Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug...

See More

Key Turning Points

2nd Resistance Point 2.35
1st Resistance Point 2.31
Last Price 2.26
1st Support Level 2.21
2nd Support Level 2.16

See More

52-Week High 29.00
Fibonacci 61.8% 18.68
Fibonacci 50% 15.49
Fibonacci 38.2% 12.31
Last Price 2.26
52-Week Low 1.99

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar